Cite
MLA Citation
Douglas Cartwright et al.. “510 Niraparib outcomes in brca wild-type platinum sensitive recurrent ovarian cancer: a comparison of real-world data to the nova trial.” International journal of gynecological cancer, vol. 30, n.d., pp. A85–A86. http://access.bl.uk/ark:/81055/vdc_100144730180.0x00001e